#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14960	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2041	723.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1393	1393	C	880	C	834	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27356	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3575	762.2	0	.	n	.	0	T695C	SNP	695	695	T	1105	1105	C	819	C	773	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27356	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3575	762.2	0	.	n	.	0	A1638G	SNP	1638	1638	A	2048	2048	G	840	G,A	798,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27356	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3575	762.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2381	2381	C	832	C,T	779,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27356	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3575	762.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2455	2455	A	876	A	842	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27356	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3575	762.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3007	3007	C	856	C,A	799,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	539	2000	folP	852	852	99.77	folP.l15.c4.ctg.1	1517	130.8	0	.	p	.	0	S68P	NONSYN	202	204	TCG	542	544	CCG	181;180;178	C;C;G	164;165;164	.	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	539	2000	folP	852	852	99.77	folP.l15.c4.ctg.1	1517	130.8	0	.	p	.	0	A204V	NONSYN	610	612	GCA	950	952	GTA	164;165;168	G;T;A	155;154;157	.	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	539	2000	folP	852	852	99.77	folP.l15.c4.ctg.1	1517	130.8	1	SNP	p	R228S	1	.	.	682	684	AGC	1022	1024	AGC	181;180;182	A;G;C	172;171;170	folP.WHO_N_01367c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4844	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3617	133.6	1	SNP	p	S91F	1	.	.	271	273	TTC	734	736	TTC	145;145;145	T;T,C;C	137;139,1;139	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4844	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3617	133.6	1	SNP	p	D95G	1	.	.	283	285	GGC	746	748	GGC	150;150;150	G;G;C	142;143;145	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4844	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3617	133.6	1	SNP	p	G95N	0	.	.	283	285	GGC	746	748	GGC	150;150;150	G;G;C	142;143;145	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1650	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1463	112.4	1	SNP	p	G45D	0	.	.	133	135	GGC	526	528	GGC	182;184;184	G;G;C	176;174;178	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	848	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1071	79.0	0	.	n	.	0	A197.	DEL	197	197	A	597	597	A	217	A	205	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4778	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3148	151.4	1	SNP	p	D86N	0	.	.	256	258	GAC	694	696	GAC	174;176;180	G;A;C	165;164;171	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4778	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3148	151.4	1	SNP	p	S87R	1	.	.	259	261	CGT	697	699	CGT	181;183;184	C,A;G,T;T	171,1;172,1;171	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4778	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3148	151.4	1	SNP	p	R87I	0	.	.	259	261	CGT	697	699	CGT	181;183;184	C,A;G,T;T	171,1;172,1;171	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4778	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3148	151.4	1	SNP	p	R87W	0	.	.	259	261	CGT	697	699	CGT	181;183;184	C,A;G,T;T	171,1;172,1;171	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4778	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3148	151.4	1	SNP	p	S88P	0	.	.	262	264	TCC	700	702	TCC	184;187;185	T;C;C	171;175;176	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3966	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2639	148.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1449	1451	GGC	186;185;182	G;G;C,T	176;176;167,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4404	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2495	175.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1272	1274	GCC	217;216;219	G;C;C	204;207;212	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4404	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2495	175.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1275	1277	ATG	219;220;216	A;T;G,T	212;208;205,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4404	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2495	175.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1287	1289	ACC	214;214;212	A;C;C	200;202;200	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4404	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2495	175.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1287	1289	ACC	214;214;212	A;C;C	200;202;200	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4404	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2495	175.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1788	1790	ACC	222;223;223	A;C;C	204;208;215	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4404	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2495	175.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1842	1844	GCG	218;219;219	G;C;G	209;208;208	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4404	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2495	175.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1842	1844	GCG	218;219;219	G;C;G	209;208;208	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4404	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2495	175.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1965	1967	GGT	193;190;193	G;G;T	183;183;185	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4404	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2495	175.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1974	1976	AGC	175;174;174	A;G;C	169;168;169	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4404	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2495	175.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1992	1994	CCG	163;167;165	C,G;C;G	124,7;128;124	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5584	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3213	173.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1665	1667	CCG	182;183;183	C,T;C;G	158,1;173;168	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2064	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1892	108.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	595	595	C	144	C	129	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	346	porB1a	984	278	90.78	porB1a.l15.c30.ctg.1	1184	26.6	0	.	p	.	0	H217N	NONSYN	649	651	CAT	931	933	AAT	18;18;18	A;A;T	18;18;18	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	346	porB1a	984	278	90.78	porB1a.l15.c30.ctg.1	1184	26.6	0	.	p	.	0	D218N	NONSYN	652	654	GAT	934	936	AAT	18;18;17	A;A;T	18;18;17	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	346	porB1a	984	278	90.78	porB1a.l15.c30.ctg.1	1184	26.6	0	.	p	.	0	V226A	NONSYN	676	678	GTA	958	960	GCA	17;17;17	G;C;A	17;17;17	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	346	porB1a	984	278	90.78	porB1a.l15.c30.ctg.1	1184	26.6	0	.	p	.	0	.	MULTIPLE	700	702	ACT	981	983	GTA	17;17;17	G;T;A	17;17;17	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	346	porB1a	984	278	90.78	porB1a.l15.c30.ctg.1	1184	26.6	0	.	p	.	0	N237fs	FSHIFT	709	709	A	990	990	A	15	A	15	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3046	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1715	176.6	1	SNP	p	G120K	1	.	.	358	360	AAG	719	721	AAG	232;235;238	A;A;G	219;218;214	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3046	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1715	176.6	1	SNP	p	N121D	0	.	.	361	363	AAC	722	724	AAC	236;236;236	A;A;C	216;218;217	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3046	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1715	176.6	1	SNP	p	A121N	1	.	.	361	363	AAC	722	724	AAC	236;236;236	A;A;C	216;218;217	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11136	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4939	225.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1344	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1053	126.7	1	SNP	p	V57M	1	.	.	169	171	ATG	526	528	ATG	293;296;291	A;T;G	281;282;275	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
